PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PolyPid Ltd (POLY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7909
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX1000, a product candidate used in orthopedic surgeries for the prevention of surgical site infections and support of bone recovery; and D-PLEX500 for use in periodontal and oral or maxillofacial surgeries to treat peri-implantitis. It develops its products using polymer-lipid encapsulation matrix technology. The company collaborates with pharmaceutical and biotechnology companies through licensing and collaboration agreements for the encapsulation of their drugs including peptides, proteins and antibodies. PolyPid is headquartered in Petach Tikva, Israel.

PolyPid Ltd (POLY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PolyPid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PolyPid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
PolyPid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PolyPid Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
PolyPid Raises USD5.3 Million in Venture Financing 10
PolyPid Raises USD22 Million in Series D Financing 11
PolyPid Raises USD8.13 Million in Venture Financing 12
PolyPid Raises US$2.4 Million In Third Round Of Financing 13
PolyPid Raises US$2 Million In Second Round Of Financing 14
Partnerships 15
PolyPid Enters Into Co-Development Agreement With MIS Implants Technologies 15
PolyPid Enters into Licensing Agreement with MIS Implants 16
Equity Offering 17
Polypid to Raise upto USD80 Million in IPO 17
PolyPid Raises USD3.8 Million in Private Placement of Shares 19
PolyPid Raises USD4 Million in Private Placement of Shares 20
PolyPid Ltd – Key Competitors 21
PolyPid Ltd – Key Employees 22
PolyPid Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
PolyPid Ltd, Medical Equipment, Key Facts, 2017 2
PolyPid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PolyPid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PolyPid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Deals By Market, 2012 to YTD 2018 8
PolyPid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PolyPid Raises USD5.3 Million in Venture Financing 10
PolyPid Raises USD22 Million in Series D Financing 11
PolyPid Raises USD8.13 Million in Venture Financing 12
PolyPid Raises US$2.4 Million In Third Round Of Financing 13
PolyPid Raises US$2 Million In Second Round Of Financing 14
PolyPid Enters Into Co-Development Agreement With MIS Implants Technologies 15
PolyPid Enters into Licensing Agreement with MIS Implants 16
Polypid to Raise upto USD80 Million in IPO 17
PolyPid Raises USD3.8 Million in Private Placement of Shares 19
PolyPid Raises USD4 Million in Private Placement of Shares 20
PolyPid Ltd, Key Competitors 21
PolyPid Ltd, Key Employees 22
PolyPid Ltd, Subsidiaries 23

List of Figures
PolyPid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PolyPid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PolyPid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PolyPid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PolyPid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
PolyPid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ElectroCore Inc (ECOR):医療機器:M&Aディール及び事業提携情報
    Summary ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company engaged in developing vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focused on headache such as episodic cluster headache, migraine, and posttraumati …
  • Reckitt Benckiser Group plc:企業のM&A・事業提携・投資動向
    Reckitt Benckiser Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reckitt Benckiser Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Axel Springer SE:企業のM&A・事業提携・投資動向
    Axel Springer SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Axel Springer SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Scottish Enterprise:電力:M&Aディール及び事業提携情報
    Summary Scottish Enterprise is a business consulting firm that Supports firms to raise wage levels. The firm provides service such as attract investment, develop management team, do business outside Scotland, develop organization, develop new products and services, among others. It offers service su …
  • Tecpetrol SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Tecpetrol SA (Tecpetrol), a subsidiary of Techint Group, is an oil and gas exploration and production company. The company acquires, explores, produces, transports and distributes oil and gas. It operates fields and blocks in Argentina, Venezuela, Bolivia, Ecuador, Mexico, Peru and Colombia. …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Shinko Electric Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Global Orthopaedic Technology Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Global Orthopaedic Technology Pty Ltd (Global) is a medical device company that designs and manufactures orthopaedic implants. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務分析
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bailian Group Co., Ltd.:企業の戦略的SWOT分析
    Bailian Group Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • LSIS Co Ltd (010120):企業の財務・戦略的SWOT分析
    LSIS Co Ltd (010120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mission Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, neurodegeneration, inflammation and others. the company uses its proprietaryDUB platform t …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Ablynx NV (ABLX)-製薬・医療分野:企業M&A・提携分析
    Summary Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional …
  • Eagle Materials Inc (EXP):企業の財務・戦略的SWOT分析
    Eagle Materials Inc (EXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Scynexis Inc (SCYX):企業の財務・戦略的SWOT分析
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company offers pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆